Case Study - Partner Identification Consulting Services

Objective :

Partners Identification for client’s early-stage oncology based clinical product for late-stage clinical development and commercialization.

Problem Statement:

A medium pharmaceutical client based in the US, with innovative formulations to treat Head and Neck Cancer, involved DelveInsight to identify a co-development partner, for the US and European region. The client was interested to involve a pharmaceutical company with experience around oncology, capabilities to develop the product through its clinical development cycle and also support commercial manufacturing for launching the product in the two regions.

Our Methodology:

Oncology Market Assessment
Assessment of Companies with Development and Commercialization Capabilities
Deal/Investment Assessment
Interest in Client’s candidate
5-10 Potential Partners

Results:

Extensive Listing of Companies with requisite capabilities
Matrix Analysis of the top 25 companies researched.
The client could assess the Top 5-10 companies that fit their strategic needs and were interested in the partnership.
Final Engagement through DelveInsight to take the discussions forward.

Related case Studies

Pipeline Assessment Competitive Benchmarking Due Diligence Competitive Intelligence Portfolio Management Asset Prioritization Mergers and Acquisitions

Sample Visuals

Get Visuals

Related Insights

Pipeline Assessment

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. [...]

View Case

Competitive Benchmarking

A large pharmaceutical client based in Europe involved DelveInsight to identify patient advocacy strategies of companies operating in the Pharma sector of the European Union, to benchmark their efforts against their competitors. [...]

View Case

Due Diligence

A medium pharmaceutical client with capabilities in novel formulations was involved in a deal with a manufacturing company for commercial-scale manufacturing of the client’s therapies. [...]

View Case